SAYARE MITCHEL 4
4 · Altimmune, Inc. · Filed Apr 6, 2018
Insider Transaction Report
Form 4
SAYARE MITCHEL
Director
Transactions
- Award
Stock Options (option to buy)
2018-04-05+35,000→ 35,000 totalExercise: $0.95Exp: 2028-04-05→ Common Stock, par value $0.0001 (35,000 underlying)
Footnotes (1)
- [F1]Fifty percent of the option will become vested and exercisable on June 30, 2018 and the remaining 50% of the option will vest and become exercisable on December 31, 2018.